PRESS RELEASE: Sign Up for a Complimentary Trial of Inside Health Policy that Expires Automatically after 30 Days
Contact: Steve Reilly
WASHINGTON, DC USA -- HEALTHCARE UPDATE NEWS SERVICE -- OCTOBER 3, 2022: Sign up for a free trial subscription to Inside Health Policy, the online news service on health care policy from the regulatory reporting experts at Inside Washington Publishers.
Inside Health Policy is a subscription-based news service from Inside Washington Publishers, a company with over four decades of experience publishing inside news from Washington, DC. Inside Health Policy is constantly updated with news from the staff of our newsletters - Inside Drug Pricing, Health Exchange Alert, Inside CMS, FDA Week, and Inside TeleHealth - plus daily blog entries and hand-picked documents, placed in a fully searchable document/news archive. It also offers special news sections such as the ACA, health reform, coronavirus, Congress, Medicare, drug pricing, and food safety.
Here is a sample of the latest Inside Health Policy stories that you can read with your free trial:
- Daily News - Exclusive health policy news is posted throughout the day.
- Health Policy Documents - an exclusive database which includes policy papers, comments, draft and final regulations, court decisions, legislative drafts, state proceedings, and many other types of information of immediate interest.
- Instant Access to the current issues of Inside CMS, FDA Week, Inside Drug Pricing, Health Exchange Alert and Inside TeleHealth. Subscribers can gain instant access to their latest issue (available within hours after the issue closes), and can print a copy, read the issue or individual articles, or search the issue by subject.
- Special news sections on over 20 topics including the ACA, Health Reform, Coronavirus, Congress, Medicare, Food Safety and more.
- Daily E-mail Alerts - we will notify you every business morning and afternoon of the latest news added to the website. Depending on your newsletter subscription, we will also notify you when the latest issues of Inside CMS, FDA Week, Inside Drug Pricing, Health Exchange Alert and Inside TeleHealth have been posted.
AHA, AMA Back Texas Docs' New Suit Over Final Surprise Billing Rule
Provider groups continue to challenge the Biden administration's interpretation of the independent dispute resolution (IDR) process created under the surprise billing law: On Wednesday the Texas Medical Association, which had already won its case over the administration's interim final rule in district court, filed another case in the same court claiming that the recently released final rule still goes beyond congressional intent and skews in favor of insurers because it asks arbiters to place more weight on the qualified payment amount (QPA) than other factors.
AHA, AMA Move to Dismiss Surprise Billing Case, But Eye New Suit
The American Hospital Association and the American Medical Association Tuesday (Sept. 20) moved to dismiss their suit against the Biden administration's interim final rule (IFR) on the independent dispute resolution process created by the No Surprises Act, saying the case became moot after the administration released a final rule.
Admin Issues RFI On Key Surprise Billing Data Transfer Provisions
The Biden administration is seeking information from stakeholders to help inform rulemaking on provisions of the surprise billing law that involve transferring data from providers to insurers, and then passing that information to consumers in advance of services, and the economic impact of those requirements.
Stakeholders Respond to Surprise Billing Reg; Status Update On Deck
Days after the Biden administration released its final surprise billing rule with new guidance on how arbiters should resolve claim disputes between payers and providers -- which responds to public comments and two federal lawsuits -- a federal district court will hear an update from parties in a separate suit that's been on hold pending release of the final rule.
You can try Inside Health Policy for the next month with absolutely no obligation, your trial will simply expire at the end of 30 days. Your trial includes online access to the newsletter you choose: Inside CMS, FDA Week, Health Exchange Alert, Inside Drug Pricing, or Inside TeleHealth - and please call us if you want access to a second newsletter with your trial. Plus, if you choose to subscribe, we'll offer you 50% off for the first year of access.
FOR E-MAIL ADDRESS CHANGE, ADD OR DELETE REQUESTS:
For more information about the 50% off, first-year savings, contact Steve Reilly at 703-562-8992, or e-mail him at email@example.com.
For changes or additions, please email your request to: listmgrbm@HealthCareUpdateNewsService.com.
For removal of your e-mail address, please click the "SafeUnsubscribe" link located in the footer of this message below to automatically remove your address from the list.